Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher R Cogle

Showing results (51-60 of 137) with videos related to

Pageof 14
Sort By:
Experimental Hematology|April 1, 2008
Marrow cell therapies for cardiovascular diseasesChristopher R Cogle, Gerard J Madlambayan, Grant Hubsher, et al.
The American Journal of Cardiology|November 3, 2021
Specialized Proresolving Mediators in Symptomatic Women With Coronary Microvascular Dysfunction (from the Women's Ischemia Trial to Reduce Events in Nonobstructive CAD [WARRIOR] Trial)Ellen C Keeley, Han J Li, Christopher R Cogle, et al.
Leukemia Research|February 21, 2012
Acute myeloid leukemia targeting by myxoma virus in vivo depends on cell binding but not permissiveness to infection in vitroGerard J Madlambayan, Eric Bartee, Manbok Kim, et al.
Public Health|December 11, 2025
Exploring the association between supportive school policy and youth tobacco useLina S Modjarrad, Jaclyn M Hall, Frederick R Kates, et al.
Blood|May 18, 2010
Leukemia regression by vascular disruption and antiangiogenic therapyGerard J Madlambayan, Amy M Meacham, Koji Hosaka, et al.
Blood|April 24, 2015
Myxoma virus suppresses proliferation of activated T lymphocytes yet permits oncolytic virus transfer to cancer cellsNancy Y Villa, Clive H Wasserfall, Amy M Meacham, et al.
Journal of Palliative Medicine|May 4, 2021
Following the Breadcrumbs of Palliative Care Financial Sustainability to Big DataSheri Kittelson, Brian Cassel, Phillip Rodgers, et al.
Chemico-Biological Interactions|October 28, 2008
Aldehyde dehydrogenase activity as a functional marker for lung cancerDeniz Ucar, Christopher R Cogle, James R Zucali, et al.
American Journal of Hematology|June 27, 2003
Busulfan, cyclophosphamide, and etoposide as conditioning for autologous stem cell transplantation in multiple myelomaChristopher R Cogle, Jan S Moreb, Helen L Leather, et al.
Lancet (London, England)|May 4, 2004
Bone marrow transdifferentiation in brain after transplantation: a retrospective studyChristopher R Cogle, Anthony T Yachnis, Eric D Laywell, et al.
Pageof 14

Showing results (51-60 of 137) with videos related to

Sort By:
Pageof 14
Experimental Hematology|April 1, 2008
Marrow cell therapies for cardiovascular diseasesChristopher R Cogle, Gerard J Madlambayan, Grant Hubsher, et al.
The American Journal of Cardiology|November 3, 2021
Specialized Proresolving Mediators in Symptomatic Women With Coronary Microvascular Dysfunction (from the Women's Ischemia Trial to Reduce Events in Nonobstructive CAD [WARRIOR] Trial)Ellen C Keeley, Han J Li, Christopher R Cogle, et al.
Leukemia Research|February 21, 2012
Acute myeloid leukemia targeting by myxoma virus in vivo depends on cell binding but not permissiveness to infection in vitroGerard J Madlambayan, Eric Bartee, Manbok Kim, et al.
Public Health|December 11, 2025
Exploring the association between supportive school policy and youth tobacco useLina S Modjarrad, Jaclyn M Hall, Frederick R Kates, et al.
Blood|May 18, 2010
Leukemia regression by vascular disruption and antiangiogenic therapyGerard J Madlambayan, Amy M Meacham, Koji Hosaka, et al.
Blood|April 24, 2015
Myxoma virus suppresses proliferation of activated T lymphocytes yet permits oncolytic virus transfer to cancer cellsNancy Y Villa, Clive H Wasserfall, Amy M Meacham, et al.
Journal of Palliative Medicine|May 4, 2021
Following the Breadcrumbs of Palliative Care Financial Sustainability to Big DataSheri Kittelson, Brian Cassel, Phillip Rodgers, et al.
Chemico-Biological Interactions|October 28, 2008
Aldehyde dehydrogenase activity as a functional marker for lung cancerDeniz Ucar, Christopher R Cogle, James R Zucali, et al.
American Journal of Hematology|June 27, 2003
Busulfan, cyclophosphamide, and etoposide as conditioning for autologous stem cell transplantation in multiple myelomaChristopher R Cogle, Jan S Moreb, Helen L Leather, et al.
Lancet (London, England)|May 4, 2004
Bone marrow transdifferentiation in brain after transplantation: a retrospective studyChristopher R Cogle, Anthony T Yachnis, Eric D Laywell, et al.
Pageof 14